author-photo

R. N. Raju

Kettering Medical Center

8

Papers

65

Citations

Citation Trend

Filter By

Papers (8) Sort By

Journal Conference Others

Extraordinary Learning Machine for Forecast of Wind Force and Moment Coefficients in Marine Vessels

2019 Journal of Engineering and Applied Sciences
- R. N. Raju
Show All
- Source
- Cite
- Save
Citations (0)
A prospective evaluation of quality of life (QOL) in a phase II trial of pemetrexed (P) plus carboplatin (Cb) ± enzastaurin (E) versus docetaxel (D) plus Cb as first-line treatment of patients (pts) with advanced non-small cell lung cancer (NSCLC)

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
A phase I dose-escalation study to a predefined dose of a transforming growth factor-β1 monoclonal antibody (TβM1) in patients with metastatic cancer

2014 International Journal of Oncology
Show All
- Source
- Cite
- Save
Citations (23)
A phase 1 study of MM-111, a bispecific HER2/HER3 antibody fusion protein, combined with multiple treatment regimens in patients with advanced HER2-positive solid tumors.

2014 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (23)
242PBIOMARKER ANALYSIS OF A PHASE 1 STUDY OF MM-111, A BISPECIFIC HER2/HER3 ANTIBODY FUSION PROTEIN, IN COMBINATION WITH MULTIPLE TREATMENT REGIMENS IN PATIENTS WITH ADVANCED HER2 POSITIVE SOLID TUMORS

2014 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
An open label phase I dose escalation study of ADH-1 in combination with chemotherapy in subjects with N-Cadherin expressing solid tumors

2008 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Preliminary results of a randomized phase II trial of pemetrexed (P) + carboplatin (Cb) ± enzastaurin (ENZ) versus docetaxel (D) + Cb as first-line treatment of patients with stage IIIB/IV non-small cell lung cancer (NSCLC)

2008 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (12)
Pemetrexed (P) in relapsed small cell lung cancer (SCLC): Preliminary results of a phase II trial

2007 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (6)